Brought to you by:
Two-year data show continued clinical improvement with VenoValve
Implantation of the VenoValve (enVVeno Medical) continues to promote stabilization of symptoms in patients with deep venous reflux at two-year follow-up. This is the headline finding of data shared yesterday during Plenary Session 6 at VAM 2025. In the abstract…
Answering the questions of appropriate outcome measures after intervention for deep reflux as promising venous valve technology emerges
“The path from initial trials to meaningful clinical data will not be easy,” writes Fedor Lurie (Toledo, USA) of new venous valve technologies. There is an old saying that goes, “As surgeons, we change the anatomy to improve physiology”. Correction…
Three-year VenoValve first-in-human trial data published
Envveno Medical has announced that its manuscript titled, “Three-year outcomes of surgical implantation of a novel bioprosthetic valve for the treatment of deep venous reflux,” has been published in the in the peer-reviewed journal, Annals of Vascular Surgery. The VenoValve was surgically…
Prosthetic valve implantation shows “vast” improvements in deep chronic venous insufficiency
“The surgical challenges of repairing deep venous reflux have been present for more than a generation. It is worth reflecting on the fact that this new technology has made the majority of patients vastly better,” were the words of principal…
AVF 2022: Emerging autogenous venous valve formation system sees ‘continual improvement’
An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual improvement since U.S. investigators started performing clinical cases with the device 18 months ago, according to…